This inventor holds 2 USPTO granted patents and 4 EPO patents. Top assignees: Epiontis Gmbh, Precision for Medicine Gmbh. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Ulrich Hoffmüller: Innovator in Epigenetic Methods
Introduction
Ulrich Hoffmüller is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of epigenetics, particularly in the identification and quantification of specific cell types within biological samples. With a total of 2 patents, Hoffmüller has developed innovative methods that enhance our understanding of cellular composition.
Latest Patents
Hoffmüller's latest patents include a groundbreaking epigenetic method for the identification of follicular T-helper (TFH) cells. This invention relates to an in vitro method for identifying follicular helper T cells by analyzing the methylation status of the leukemia inhibitory factor (LIF) gene region. The method allows for the identification of follicular helper T cells on an epigenetic level, distinguishing them from other blood cells in complex samples. Additionally, he has developed a method for identifying the quantitative cellular composition in a biological sample, referred to as an epigenetic haemogram. This method utilizes a normalization standard to provide a comprehensive picture of cellular composition, applicable to various biological samples.
Career Highlights
Throughout his career, Hoffmüller has worked with notable companies such as Precision for Medicine GmbH and Epiontis GmbH. His expertise in epigenetics has positioned him as a key player in advancing methodologies that improve cellular analysis.
Collaborations
Hoffmüller has collaborated with Sven Olek, further enhancing the impact of his work in the field of epigenetics.
Conclusion
Ulrich Hoffmüller is a prominent inventor whose innovative methods in epigenetics are paving the way for advancements in cellular analysis. His contributions are significant in the ongoing research and understanding of biological samples.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
